Literature DB >> 12585964

Synergism between nuclear receptors bound to specific hormone response elements of the hepatic control region-1 and the proximal apolipoprotein C-II promoter mediate apolipoprotein C-II gene regulation by bile acids and retinoids.

Dimitris Kardassis1, Anastasia Roussou, Paraskevi Papakosta, Konstantinos Boulias, Iannis Talianidis, Vassilis I Zannis.   

Abstract

We have shown previously that the hepatic control region 1 (HCR-1) enhances the activity of the human apolipoprotein C-II (apoC-II) promoter in HepG2 cells via two hormone response elements (HREs) present in the apoC-II promoter. In the present paper, we report that the HCR-1 selectively mediates the transactivation of the apoC-II promoter by chenodeoxycholic acid (CDCA) and 9- cis -retinoic acid. CDCA, which is a natural ligand of farnesoid X receptor alpha (FXRalpha), increases the steady-state apoC-II mRNA levels in HepG2 cells. This increase in transcription requires the binding of retinoid X receptor alpha (RXRalpha)-FXRalpha heterodimers to a novel inverted repeat with one nucleotide spacing (IR-1) present in the HCR-1. This element also binds hepatocyte nuclear factor 4 and apoA-I regulatory protein-1. Transactivation of the HCR-1/apoC-II promoter cluster by RXRalpha-FXRalpha heterodimers in the presence of CDCA was abolished by mutations either in the IR-1 HRE of the HCR-1 or in the thyroid HRE of the proximal apoC-II promoter, which binds RXRalpha-thyroid hormone receptor beta (T3Rbeta) heterodimers. The same mutations also abolished transactivation of the HCR-1/apoC-II promoter cluster by RXRalpha-T3Rbeta heterodimers in the presence of tri-iodothyronine. The findings establish synergism between nuclear receptors bound to specific HREs of the proximal apoC-II promoter and the HCR-1, and suggest that this synergism mediates the induction of the HCR-1/apoC-II promoter cluster by bile acids and retinoids.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12585964      PMCID: PMC1223391          DOI: 10.1042/BJ20021532

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  44 in total

Review 1.  Insights into apolipoprotein C metabolism from transgenic and gene-targeted mice.

Authors:  M C Jong; L M Havekes
Journal:  Int J Tissue React       Date:  2000

2.  Binding specificity and modulation of the human ApoCIII promoter activity by heterodimers of ligand-dependent nuclear receptors.

Authors:  S N Lavrentiadou; M Hadzopoulou-Cladaras; D Kardassis; V I Zannis
Journal:  Biochemistry       Date:  1999-01-19       Impact factor: 3.162

Review 3.  FXR, a bile acid receptor and biological sensor.

Authors:  H Tu; A Y Okamoto; B Shan
Journal:  Trends Cardiovasc Med       Date:  2000-01       Impact factor: 6.677

4.  A short proximal promoter and the distal hepatic control region-1 (HCR-1) contribute to the liver specificity of the human apolipoprotein C-II gene. Hepatic enhancement by HCR-1 requires two proximal hormone response elements which have different binding specificities for orphan receptors HNF-4, ARP-1, and EAR-2.

Authors:  P Vorgia; V I Zannis; D Kardassis
Journal:  J Biol Chem       Date:  1998-02-13       Impact factor: 5.157

5.  Identification of the DNA binding specificity and potential target genes for the farnesoid X-activated receptor.

Authors:  B A Laffitte; H R Kast; C M Nguyen; A M Zavacki; D D Moore; P A Edwards
Journal:  J Biol Chem       Date:  2000-04-07       Impact factor: 5.157

6.  Role of Smad proteins and transcription factor Sp1 in p21(Waf1/Cip1) regulation by transforming growth factor-beta.

Authors:  K Pardali; A Kurisaki; A Morén; P ten Dijke; D Kardassis; A Moustakas
Journal:  J Biol Chem       Date:  2000-09-22       Impact factor: 5.157

7.  A hormone response element in the human apolipoprotein CIII (ApoCIII) enhancer is essential for intestinal expression of the ApoA-I and ApoCIII genes and contributes to the hepatic expression of the two linked genes in transgenic mice.

Authors:  H Y Kan; S Georgopoulos; V Zannis
Journal:  J Biol Chem       Date:  2000-09-29       Impact factor: 5.157

8.  Mammalian hepatocyte differentiation requires the transcription factor HNF-4alpha.

Authors:  J Li; G Ning; S A Duncan
Journal:  Genes Dev       Date:  2000-02-15       Impact factor: 11.361

9.  Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis.

Authors:  C J Sinal; M Tohkin; M Miyata; J M Ward; G Lambert; F J Gonzalez
Journal:  Cell       Date:  2000-09-15       Impact factor: 41.582

10.  Identification of a bile acid-responsive element in the human ileal bile acid-binding protein gene. Involvement of the farnesoid X receptor/9-cis-retinoic acid receptor heterodimer.

Authors:  J Grober; I Zaghini; H Fujii; S A Jones; S A Kliewer; T M Willson; T Ono; P Besnard
Journal:  J Biol Chem       Date:  1999-10-15       Impact factor: 5.157

View more
  8 in total

1.  Stable isotope labeling with amino acids in cell culture (SILAC)-based quantitative proteomics study of a thyroid hormone-regulated secretome in human hepatoma cells.

Authors:  Cheng-Yi Chen; Lang-Ming Chi; Hsiang-Cheng Chi; Ming-Ming Tsai; Chung-Ying Tsai; Yi-Hsin Tseng; Yang-Hsiang Lin; Wei-Jan Chen; Ya-Hui Huang; Kwang-Huei Lin
Journal:  Mol Cell Proteomics       Date:  2011-12-14       Impact factor: 5.911

Review 2.  Apolipoprotein C-II: New findings related to genetics, biochemistry, and role in triglyceride metabolism.

Authors:  Anna Wolska; Richard L Dunbar; Lita A Freeman; Masako Ueda; Marcelo J Amar; Denis O Sviridov; Alan T Remaley
Journal:  Atherosclerosis       Date:  2017-10-20       Impact factor: 5.162

3.  Serum apolipoprotein C-II is prognostic for survival after pancreatic resection for adenocarcinoma.

Authors:  A Xue; J W Chang; L Chung; J Samra; T Hugh; A Gill; G Butturini; R C Baxter; R C Smith
Journal:  Br J Cancer       Date:  2012-11-20       Impact factor: 7.640

4.  Non-alcoholic Fatty liver disease: the bile Acid-activated farnesoid x receptor as an emerging treatment target.

Authors:  Michael Fuchs
Journal:  J Lipids       Date:  2011-12-07

5.  The Fox and the Rabbits-Environmental Variables and Population Genetics (1) Replication Problems in Association Studies and the Untapped Power of GWAS (2) Vitamin A Deficiency, Herpes Simplex Reactivation and Other Causes of Alzheimer's Disease.

Authors:  C J Carter
Journal:  ISRN Neurol       Date:  2011-07-12

6.  STAT1 interacts with RXRα to upregulate ApoCII gene expression in macrophages.

Authors:  Violeta G Trusca; Irina C Florea; Dimitris Kardassis; Anca V Gafencu
Journal:  PLoS One       Date:  2012-07-12       Impact factor: 3.240

Review 7.  FXR an emerging therapeutic target for the treatment of atherosclerosis.

Authors:  Andrea Mencarelli; Stefano Fiorucci
Journal:  J Cell Mol Med       Date:  2010-01       Impact factor: 5.310

Review 8.  Bile acid nuclear receptor FXR and digestive system diseases.

Authors:  Lili Ding; Li Yang; Zhengtao Wang; Wendong Huang
Journal:  Acta Pharm Sin B       Date:  2015-02-25       Impact factor: 11.413

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.